Ken Griffin Applied Therapeutics Inc. Put Options Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.25 - $7.4 $15,525 - $51,060
-6,900 Reduced 49.29%
7,100 $48,000
Q4 2023

Feb 14, 2024
BUY
$1.84 - $3.35 $25,576 - $46,565
13,900 Added 13900.0%
14,000 $46,000
Q3 2023

Nov 14, 2023
SELL
$1.26 - $2.77 $630 - $1,385
-500 Reduced 83.33%
100 $0
Q2 2023

Aug 14, 2023
BUY
$0.77 - $1.8 $462 - $1,080
600 New
600 $0
Q4 2022

Feb 14, 2023
BUY
$0.65 - $1.12 $65 - $112
100 New
100 $0

Others Institutions Holding APLT

# of Institutions
100
Shares Held
94.1M
Call Options Held
5.83M
Put Options Held
231K
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $247M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email